Knocking on Closed Doors: Host Interferons Dynamically Regulate Blood-Brain Barrier Function during Viral Infections of the Central Nervous System
Open accessAbstract
The central nervous system (CNS) is among the most important organ systems, integrating information inputs and coordinating the activity of all other body systems. Like many organ systems, the CNS is susceptible to infection by pathogenic microorganisms, including many arboviruses that are considered neurotropic because they are able to achieve robust replication in neural cells. Neurotropic arboviruses capable of infecting the CNS include members of the Flaviviridae (e.g., West Nile and Japanese encephalitis viruses), Bunyaviridae (La Cross and Rift Valley Fever viruses), and Togaviridae (Alphavirus species) families, all RNA viruses that are maintained in complex life cycles involving a nonhuman primary vertebrate and a primary arthropod vector [1]. A variety of mechanisms exist to protect the CNS from the entry and infection of neurotropic viruses, including innate immune responses and multilayer barriers formed by diverse host cell types [2]. However, many arboviruses gain access to the CNS either as free virions, within motile infected cells, and/or by using axonal transport mechanisms of peripheral nerves that directly enter or form synapses within the CNS. Viruses that enter via the bloodstream must cross CNS endothelial barriers that exhibit unique specializations, collectively termed the blood-brain barrier (BBB).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Interferons produced during viral infections, such as West Nile virus, protect blood-brain barrier integrity to virions by restricting their entry into brain parenchyma.
“Interferons produced during viral infections, e.g., West Nile virus, protect the BBB integrity to virions by restricting their entry into brain parenchyma (131, 348).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 22 · Cited by 42
Research works printed but not linked: 20
- [1]Wasay M, Khatri IA, Abd-Allah F (2015) Arbovirus infections of the nervous system: current trends and future threats. Neurology 84: 421– 423. 10.1212/WNL.0000000000001177 25628429 · DOI
- [2]Daniels BP, Klein RS (2015) Viral sensing at the blood-brain barrier: New roles for innate immunity at the CNS vasculature. Clin Pharmacol Ther 97: 372– 379. 10.1002/cpt.75 25670037 · DOI
- [3]Prat A, Biernacki K, Wosik K, Antel JP (2001) Glial cell influence on the human blood-brain barrier. Glia 36: 145– 155. 11596123
- [4]Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16: 1– 13. 15207256
- [5]Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7: 41– 53. 16371949
- [6]Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD (2006) Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1: 223– 236. 18040800
- [8]Pinto AK, Ramos HJ, Wu X, Aggarwal S, Shrestha B, et al (2014) Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis. PLoS Pathog 10: e1004086 10.1371/journal.ppat.1004086 24743949 PMC3990718 · DOI
- [9]Kraus J, Ling AK, Hamm S, Voigt K, Oschmann P, et al (2004) Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro. Ann Neurol 56: 192– 205. 15293271
- [10]Markowitz CE (2007) Interferon-beta: mechanism of action and dosing issues. Neurology 68: S8– 11. 17562848
- [11]Daniels BP, Holman DW, Cruz-Orengo L, Jujjavarapu H, Durrant DM, et al (2014) Viral pathogen-associated molecular patterns regulate blood-brain barrier integrity via competing innate cytokine signals. MBio 5: e01476– 01414. 10.1128/mBio.01476-14 25161189 PMC4173776 · DOI · Paper page
- [12]Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420: 629– 635. 12478284
- [13]Too LK, Ball HJ, McGregor IS, Hunt NH (2014) The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis. Brain Behav Immun 40: 252– 268. 10.1016/j.bbi.2014.02.020 24607660 · DOI
- [14]Chai Q, He WQ, Zhou M, Lu H, Fu ZF (2014) Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection. J Virol 88: 4698– 4710. 10.1128/JVI.03149-13 24522913 PMC3993813 · DOI
- [15]Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, et al (2005) Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 16: 5040– 5052. 16055505 PMC1237102
- [16]Ando H, Sato T, Tomaru U, Yoshida M, Utsunomiya A, et al (2013) Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. Brain 136: 2876– 2887. 10.1093/brain/awt183 23892452 · DOI
- [17]Sommereyns C, Paul S, Staeheli P, Michiels T (2008) IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4: e1000017 10.1371/journal.ppat.1000017 18369468 PMC2265414 · DOI
- [18]Pott J, Mahlakoiv T, Mordstein M, Duerr CU, Michiels T, et al (2011) IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A 108: 7944– 7949. 10.1073/pnas.1100552108 21518880 PMC3093475 · DOI
- [19]Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM, et al (2015) Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity. Science 347: 269– 273. 10.1126/science.1258100 25431489 PMC4398891 · DOI
- [20]Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A, et al (2015) Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection. Science 347: 266– 269. 10.1126/science.1258025 25431490 PMC4409937 · DOI
- [21]Lazear HM, Daniels BP, Pinto AK, Huang AC, Vick SC, et al (2015) Interferon λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Science Translational Medicine 7: 284ra259. PMC4435724 25904743
- Authors
- Daniels, B. P., & Klein, R. S.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Klein, Robyn S.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-09-17
- Volume
- 11
- Issue
- 9
- Pages
- e1005096
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC4574746
- OpenAlex
- W2198727487
- Cited by
- 42
- References
- 22
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 1
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Foundation (1143954)
- National Institutes of Health (DTRA1-11-16-BRCWMD-BAA, DGE-1143954, AI083019)
- Defense Threat Reduction Agency
- National Institute of Allergy and Infectious Diseases (U19AI083019, AI083019)
- National Institute of Neurological Disorders and Stroke (NS 052632, NS059560, P01NS059560, R01NS052632)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Keywords
- blood-brain barrier, viral infections of the central nervous system, innate immune response, Flaviviridae, Bunyaviridae, Togaviridae, West Nile virus, Japanese encephalitis virus, Rift Valley fever virus, alphavirus, axonal transport
- MeSH terms
- Animals, Blood-Brain Barrier, Humans, Immunity, Innate, Interferons, Virus Physiological Phenomena, Central Nervous System Viral Diseases, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review